Corporate News 14-Feb-24
Board of Natco Pharma recommends interim dividend
Of Rs 1.25 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 14 February 2024, inter alia, have recommended the dividendinterim of Rs 1.25 per equity Share (i.e. 62.5%) , subject to the approval of the shareholders.
Previous News
Natco Pharma
( Results - Analysis 15-Nov-23 14:30 )
Board of Natco Pharma recommends Second Interim Dividend
( Corporate News - 16-Nov-23 09:39 )
Natco Pharma Ltd spurts 1.79%
( Hot Pursuit - 26-Dec-23 13:05 )
Natco Pharma Ltd slips for fifth straight session
( Hot Pursuit - 19-Sep-24 13:35 )
Natco Pharma Ltd spurts 0.67%, gains for fifth straight session
( Hot Pursuit - 03-Jan-24 13:00 )
Natco Pharma receives warning letter from USFDA for its Kothur unit
( Corporate News - 09-Apr-24 10:35 )
Natco Pharma gains as board OKs Rs 210-cr share buyback
( Hot Pursuit - 08-Mar-23 12:09 )
Natco Pharma launches two CTPR pesticide products
( Corporate News - 04-Oct-22 12:55 )
Natco Pharma to hold AGM
( Corporate News - 06-Sep-23 17:31 )
Board of Natco Pharma approves buyback of shares up to Rs 700 cr
( Corporate News - 08-Mar-23 11:50 )
Natco Pharma consolidated net profit rises 327.20% in the June 2022 quarter
( Results - Announcements 09-Aug-22 15:33 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
